Testosterone Suppression in Patients with Intermediate Risk Prostate Cancer Treated with External Beam Radiotherapy Alone

被引：0
|
作者：
Nabid, A. [1 ]
Carrier, N. [1 ]
Vigneault, E. [2 ]
Souhami, L. [3 ]
Lemaire, C. [4 ]
Brassard, M. [5 ]
Bahoric, B. [6 ]
Archambault, R. [7 ]
Vincent, F. [8 ]
Nguyen, T. [9 ]
机构：
[1] CHUS Hop Fleurimont, Sherbrooke, PQ, Canada
[2] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada
[3] Ctr Univ Sante McGill, Montreal, PQ, Canada
[4] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[5] Ctr Sante & Serv Sociaux Chicoutimi, Chicoutimi, PQ, Canada
[6] Hop Gen Juif, Montreal, PQ, Canada
[7] Hop Gatineau, Gatineau, PQ, Canada
[8] Ctr Hosp Reg Trois Rivieres, Trois Rivieres, PQ, Canada
[9] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [21] Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients
    Miszczyk, Marcin
    Magrowski, Lukasz
    Krzysztofiak, Tomasz
    Stando, Rafak
    Majewski, Wojciech
    Stawiski, Konrad
    Masri, Oliwia
    Ciepal, Jakub
    Depowska, Gabriela
    Chimiak, Krystyna
    Bylica, Gabriela
    Czapla, Barbara
    Masri, Makgorzata
    Cichur, Franciszek
    Jabkonska, Iwona
    Gmerek, Marta
    Nowicka, Zuzanna
    Wojcieszek, Piotr
    Sadowski, Jacek
    Suwinski, Rafak
    Rajwa, Pawel
    Goldner, Gregor
    Moll, Matthias
    RADIOTHERAPY AND ONCOLOGY, 2023, 183
  • [22] Factors Influencing PSA Kinetics after External Beam Radiotherapy for Intermediate Risk Prostate Cancer
    Taussky, D.
    Delouya, G.
    Kaufman, G.
    Bahary, J.
    Nguyen, T.
    Despres, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S354 - S355
  • [23] The Importance of an Exponential PSA Decline After External Beam Radiotherapy For Intermediate Risk Prostate Cancer
    Delouya, G.
    Kaufman, G.
    Sylvestre, M.
    Nguyen, T.
    Bahary, J.
    Taussky, D.
    Despres, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S444 - S444
  • [24] Intermediate Risk Prostate Cancer Treated with Hypofractionated External Beam Radiotherapy without Androgen Deprivation: Preliminary Results and Toxicity Analysis
    Dal Pra, A. L.
    Faria, S.
    Cury, F.
    David, M.
    Duclos, M.
    Shenouda, G.
    Souhami, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S189 - S189
  • [25] SCATTERED RADIATION TO THE TESTIS AND TESTOSTERONE SECRETION IN PROSTATE CANCER TREATED WITH RADIOTHERAPY ALONE
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Thu Van Nguyen
    Vavassis, Peter
    Bahoric, Boris
    Brassard, Marc-Andre
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Wilke, Derek
    Hubert-Tremblay, Vincent
    Souhami, Luis
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S26 - S27
  • [26] Conditional Risk and Predictive Factors Associated with Late Toxicity for Prostate Cancer Patients Treated with External Beam Radiotherapy Alone on Randomized Trial RTOG 0126
    Alexander, G. S.
    Krc, R. F.
    Assif, J. W.
    Sun, K.
    Molitoris, J. K.
    Tran, P. T.
    Bentzen, S. M.
    Rana, Z. H.
    Mishra, M. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S94 - S94
  • [27] Acute/late toxicities and predictors of erectile function in patients with intermediate risk prostate cancer treated with combined modality external beam radiotherapy and interstitial brachytherapy
    Hirsh, A. Z.
    Yan, W.
    Castan, E.
    Hirsh, A. L.
    Brennan, J. S.
    Christos, P. J.
    Parashar, B.
    Nori, D.
    Wernicke, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S499 - S499
  • [28] An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external-beam radiotherapy
    Gabriele, Domenico
    Guarneri, Alessia
    Bartoncini, Sara
    Munoz, Fernando
    Tamponi, Matteo
    Russo, Filippo
    Stamatakos, Georgios
    Guiot, Caterina
    Regge, Daniele
    Ricardi, Umberto
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [29] WHEN BIOCHEMICAL FAILURE DOES NOT MEAN CANCER RECURRENCE IN MEN TREATED BY EXTERNAL BEAM RADIOTHERAPY AND ADJUVANT HORMONES FOR INTERMEDIATE RISK PROSTATE CANCER
    Busca, Ionut
    Aljawi, Ghufran
    MacRae, Robert
    Eapon, Libni
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S49 - S49
  • [30] When Biochemical Failure Does Not Mean Cancer Recurrence in Men Treated by External Beam Radiotherapy and Adjuvant Hormones for Intermediate Risk Prostate Cancer
    Busca, I.
    Aljawi, G. A.
    MacRae, R. M.
    Eapen, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E268 - E268
12345